Tourmaline Bio Inc. (TRML) — Long-term Investment Intensity

Latest as of June 2025: 6.4%

Tourmaline Bio Inc. (TRML) has a Long-term Investment Intensity of 6.4% as of June 2025. Long-term investments of $17.18 Million represent 6.4% of total assets of $269.30 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Tourmaline Bio Inc. cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

LT Investment Intensity

6.4%
LT Investments / Total Assets

Long-term Investments

$17.18 Million
USD

Total Assets

$269.30 Million
USD

Country

USA
NASDAQ

Tourmaline Bio Inc. Long-term Investment Intensity (2024–2024)

This chart shows how Tourmaline Bio Inc.'s Long-term Investment Intensity has evolved across 1 annual periods from 2024 to 2024. As of June 2025, the intensity stands at 6.4%, reflecting long-term investments of $17.18 Million against total assets of $269.30 Million USD. Explore debt repayment capacity of Tourmaline Bio Inc. to assess how comfortably operating cash covers total debt obligations.

Annual Long-term Investment Intensity for Tourmaline Bio Inc. (2024–2024)

The table below presents the year-by-year Long-term Investment Intensity for Tourmaline Bio Inc. from 2024 to 2024, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see TRML stock market capitalisation.

Year LT Investment Intensity LT Investments (USD) Total Assets Change (pp)
2024 11.9% $36.63 Million $309.00 Million
pp = percentage points